CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 24/100 — a percentile rank of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s fundamentals against Services peers, weakest on growth. A quality ranking, not a price prediction.
| Market cap | $13.7B |
| P / S | 3.4× |
| EV / EBITDA | 21.1× |
| Gross margin | 32.7% |
| Operating margin | 2.3% |
| Net margin | -5.9% |
| Return on equity | -8.4% |
| ROIC | 2.2% |
| Revenue growth | -0.7% |
| Debt / equity | 0.9× |
| Dividend yield | 0.0% |
Is CHARLES RIVER LABORATORIES INTERNATIONAL, INC. overvalued? P/S looks overvalued vs its 5-year range; EV/EBITDA looks overvalued vs its 5-year range; P/B looks overvalued vs its 5-year range.
Independent of the events above — derived from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact